Daily Top News – August 28, 2020

August 28, 2020
Larvol Pulse News

llllllllll low molecular weight dextran sulfate (ILB) / TikoMedTIKOMED Granted Orphan Medicinal Drug Designation for ILB for the Treatment of Amyotrophic Lateral Sclerosis by the European Commission (Digital Journal) - Aug 28, 2020 - “TIKOMED…announced that the European Commission has granted Orphan Drug Designation to its lead drug candidate ILB® for the treatment of patients with amyotrophic lateral sclerosis (ALS)…”llllllllll Ad26.COV2-S / J&J, BARDAJ&J's Janssen to begin Phase II COVID-19 vaccine trials next week in Spain (Reuters) - Aug 28, 2020 - "Johnson & Johnson’s Janssen unit will begin Phase II trials for its COVID-19 vaccine in Spain, the Netherlands and Germany next week, Spanish health minister Salvador Illa announced on Friday....The trial will last two months and include 550 participants across the three countries, including 190 people in Spain, Illa told a news conference in Madrid."llllllllll Formalin-inactivated and alum-adjuvanted candidate vaccine + CpG 1018 / Dynavax, Sinovac; PiCoVacc / Sinovac, Bio Farma IndonesiaSinovac's Covid Vaccine Candidate Approved For Emergency Use In China: Report (NDTV) - Aug 28, 2020 - "China National Biotec Group (CNBG)...also said it had obtained emergency use approval for a coronavirus vaccine candidate....CNBG, which has two vaccine candidates in phase 3 clinical trials, did not say which of its vaccines had been cleared for emergency use."